We use cookies to improve your experience on this site. By viewing our pages, you give us consent to use cookies. Find out more.

Status: Active

Zone V makes the latest tablets and smartphones work for the older generation with low eyesight, deficient hearing or dexterity. The company has redefined a global platform that is providing access to the services that are difficult to use. They have a technological partnership with Samsung and are a Samsung Managed Solutions Partner. The company also creates inclusively accessible technology, services, and applications for more smoother and viable communication. The executive team of this company includes health, telecoms, and wellness fields. With the proceeds, Zone V will widen the digital divide for the older smartphones users by working tirelessly to build new innovative communication solutions.

read more read less

Zone V Rating Report

Rated on 06/04/2020

Pitch Rated

84%

Gold

Management

80%

Product

85%

Investment

87%

Pitch rating powered by CROWDRATING

What the ratings mean

  • 49% and under
    We suggest potential investors carry out further study of their own
    50-64%
    Room for improvement
    65-79%
    Worth considering
    80%+
    Gold rating, our highest rating
Click here for more information on our ratings
Login to view the full report

Management 80%

Skills 82%
The CEO of the company is a creative, entrepreneurial board member who comes with leadership skills in multidisciplinary technology, business development and strategy advisory. He also holds a PhD degree in the field of Electronics and Communication. The Head of Product is skilled in developing new ideas and design solutions. He created a wide range of creative and business explorations, from high and low technology product development to new business ventures in entertainment and communications. Also, the financial advisor of the company is an expert in handling complex, multi-national and multi-billion Euro businesses in blue-chip companies (i.e. Nokia, Motorola, Lenovo).


0 comments

Log in to comment


Funding progress



More from Technology

Zapaygo allows consumers to order ahead at coffee shops, food outlets, restaurants, bars, events spaces, stadiums, and many other venues, improving customer experience while increasing venue revenues. The app also has a loyalty program for its users, RewardZ. This blockchain, digital rewards token is a key offering by Zapaygo to chain and individual merchants who can redeem RewardZ Tokens. Using Zaypaygo allows venues to reduce time taking orders by 40% and increase their sales by 30%. The company has developed an innovative technology platform that has identified core venues & corporate partners in the UK as initial target markets and is ready to scale. With the funds received, the company is focused on covering customer/corporate convenience in collecting F&B (Food & Beverage) and experience growth similar to the success experienced by apps like UberEats and Deliveroo. It also aims to offer 'order to delivery' end to end services.

Pitch Rated

80%

Gold

rating powered by

CROWD RATING™

pledged: 227% days to go: 12 investment: £568,440
3DUserNet is an online portal for viewing and collaborating on 3D data projects. Its SaaS platform enables team members in engineering and construction companies to store, view, and navigate, work on and collaborate online, through any modern browser on any smart device, on all their 3D data without the need for installed software. The company has been working with sectors such as surveying, policing, civil engineering, security, road safety, and defence. Since its inception, it has added multiple measurement tools including clip boxes, line of sight, checkpoint tool, and slope tool on its platform. The company is seeking funds of up to £400,000, at a pre-money valuation of £1.6 million under which it is offering investors making up the first £200,000 a discounted share price of £3.4733. Investors joining in for the remaining £200,000 thereafter will purchase a share for £4.6622. The funds raised will be used for further platform development, sales and marketing, and for additional working capital.
pledged: 0% days to go: 24 investment: Unknown
Aura is a simple, one of a kind, online solution to help people and those closest to them prepare for the end of life in a practical & emotional sense. Upon registering on the platform, the person needs to set up a profile and add the people he/she wishes to be connected with. Post this, the user can dip into practical information, illustrate end-of life wishes, write one's life story, or send goodbye messages, all of which are highly customisable, on the platform for their loved ones to see. The company's vision is to manage end of life practicalities, leave a legacy that can be controlled, and prepare the afflicted person and his/her family in all ways possible for the future. The company already has a promo website, and with the funds invested, it will develop its Minimum Viable Product (MVP) to ensure a steady base of users join its platform.
pledged: 130% days to go: 26 investment: £162,381
Ceryx Medical is a medical technological entity that is developing bioelectronics based on a unique, patent-protected, chip technology that can mimic nerve centres within the body called Central Pattern Generators (CPGs). CPGs help to control a range of autonomic or rhythmical processes within the body such as peristalsis, heart rate, and even walking. The Ceryx system resembles a traditional cardiac pacing device that holds a lot of promise in potentially alleviating incidences of heart failure leading to a therapeutic effect on patient health. In the UK, this is a day surgery procedure under local anaesthetic with a basic system costing around £3500. The device, therefore, offers a cost-effective, single procedure solution for this currently intractable disease. Treatment expenditures on heart failure cases in the EU amount to almost £35 billion. The Ceryx system is a potential disruptor in this segment and offers multiple potential applications. The company is targeting £500,000 as part of £1 million round. With the investment, the company aims to produce a data package that mimics those used to support 510k/NDA applications, as mandated by the US Food and Drug Administration (FDA), for current devices and drugs used to treat heart failure.
pledged: 7% days to go: Expired investment: £10,000
Invluencer is a Venture Capital (VC) company with a disruptive economic model designed to bring VC to the masses. The company allows investors to enhance investment capability through an Intelligent Distributed Due Diligence Platform called i3D. Through its technology-driven swarm intelligence feedback, Invluencer boosts decision making and greater investment capability between investors and company representatives. This is undertaken by creating a smart-contract enabled 'Intelligent Wallet' for autonomous investment in vetted high-growth companies facilitated by Invluencer’s unique Multi-Asset Platform (I-MAP) and i3D. Through these technologies, the company aims to simplify investment and open unprecedented liquidity between worthy companies and accredited investors. With the funds received, the company will continue the development of due diligence & fund management platforms.
pledged: 0% days to go: 31 investment: Unknown

  • Unknown
    pledged
  • 0%
    of goal
  • Active
    15 May 2020

    £750,000
    target

    £3,000,000
    pre-money valuation

    Unknown
    investors

    £Unknown
    pledge per investor

    06627807
    company number

    Active
    company status

    24/06/2008
    incorporated 12 years

  • Internet Business Awards Category Award Winner 2015
  • Hertfordshire Business Awards Finalist 2014

As seen in:

  • The Guardian
  • Financial Times
  • Yahoo! Finance
  • The Times
  • The Daily Telegraph